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Abstract--Accurately predicting the treatment outcome plays a greatly important role in tailoring and 
adapting a treatment planning in cancer therapy. Although the development of different modalities and 
personalized medicine can greatly improve the accuracy of outcome prediction, they also bring the three 
mainly simultaneous challenges including multi-modality, multi-classifier and multi-criteria, which are 
summarized as multifactorial outcome prediction (MFOP) in this paper. Compared with traditional 
outcome prediction, MFOP is a more generalized problem. To handle this novel problem, based on the 
recent proposed radiomics, we propose a new unified framework termed as multifaceted radiomics (M-
radiomics). M-radiomics trains multiple modality-specific classifiers first and then optimally combines 
the output from the outputs of different classifiers which are trained according to multiple different 
criteria such as sensitivity and specificity. It considers multi-modality, multi-classifier and multi-criteria 
into a unified framework, which makes the prediction more accurate. Furthermore, to obtain the more 
reliable predictive performance which is to maximize the similarity between predicted output and labelled 
vector, a new validation set based reliable fusion (VRF) strategy and reliable optimization models as well 
as a new recursive two stage hybrid optimization algorithm (RTSH) were also developed. Two clinical 
problems for predicting distant metastasis and locoregional recurrence in head & neck cancer were 
investigated to validate the performance and reliability of the proposed M-radiomics. By using the 
proposed RF strategy and RTSH optimization algorithm, the experimental results demonstrated that M-
radiomics performed better than current radiomic models that rely on a single objective, modality or 
classifier.     
Index Terms—Outcome prediction, radiomics, classifier fusion, evidential reasoning rule, multi-objective 
evolutionary algorithm 
I. Introduction 
      Outcome prediction in cancer treatment refers to staging, tumor response to therapy, rates of local 
recurrence, evolution to metastatic disease, development of toxicity during follow up, or a combination of 
these endpoints [1]. Accurately predicting outcomes prior to or even during therapy is of great value, as it 
facilitates more effective treatment planning for individual patients [2]. For example, for patients in early 
stage non-small cell lung cancer, accurately predicting distant failure after stereotactic body radiation 
therapy (SBRT) may adopt additional systemic therapy so as to improve the overall survival [3]. 
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Similarly, when receiving external beam radiation therapy with concurrent chemotherapy and 
intracavitary brachytherapy, at least 20% patients with locally advanced cervical cancer still develop 
distant failure [4]. As such, it is essential to predict distant failure for patients with high risk so that better 
treatment outcomes with intensified treatment modalities can be achieved. In head & neck cancer, since 
one third of the body’s lymph nodes are located in the head and neck, lymph node metastases has become 
one of the most important prognostic factor and early prediction is necessary for treatment optimization 
[5]. As such, building an accurate and reliable treatment outcome prediction model is of great importance 
in cancer care. 
      With the development of modern diagnostic as well as treatment modalities, and a great progress in 
personalized medicine has, however, created new three important challenges simultaneously for 
predicting treatment outcome. First of all, different source of information are always available for 
building predictive model, e.g., different imaging modalities such as PET, CT and MRI. However, the 
challenge is how to optimally integrate available and diverse multimodal information in a quantitative 
way so that the reliable and accurate outcomes can be provided. For example, FDG-PET scanning 
measures glucose metabolism, while CT scanning provides attenuation coefficient information for x-rays. 
So a simple combination of the features extracted from these different modalities may not yield an 
optimal prediction. Secondly, the progress of artificial intelligence and machine learning has provided 
multiple choices for model construction. However, different techniques (classifier) are always associated 
with distinct inherent limitations and the choice of modelling technique has been shown to affect the 
prediction performance. Therefore, the challenge is how to choose an “optimal” or a “preferred” classifier 
for a particular application [6]. Thirdly, it is always difficult to make balance between sensitivity and 
specificity especially when positive and negative cases are imbalanced in training dataset [3]. For 
example, when the number of patients with distant failure in lung SBRT is greatly lower than the patients 
without distant failure, the sensitivity will be low even though the accuracy may be high as it is used as 
the objective function. So the challenge is how to balance the two objects (sensitivity and specificity). 
      The above three challenges can summarized as multi-modality, multi-classifier and multi-criteria. Due 
to the importance of the three challenges and to distinguish from the traditional outcome prediction 
problem, a new problem named as multifactorial outcome prediction (MFOP) is introduced for 
describing the outcome prediction with three challenges for the first time. The aim of MFOP is to get 
more accurate as well as reliable and interpretable predictive results. Compared with the traditional 
outcome prediction, MFOP is a more generalized problem framework.  
      With the recent advances in medical imaging technology, radiomics, referring to extracting and 
analyzing a huge number of quantitative image features [7-10], provides a unprecedented opportunity to 
improve personalized treatment assessment [11]. In a recent study, radiomic features were extracted from 
CT images in [12] to predict survival time in NSCLC with an accuracy of 77.5%. When CT based 
radiomics features were combined with the clinical model to predict distant metastasis in lung 
adenocarcinoma, the performance was significantly improved [13]. By selecting radiomic features from 
FDG-PET images in [2], the accuracy for predicting lung tumor recurrence can achieve 0.94. Although it 
is demonstrated that radiomics has achieved great success for handling traditional outcome prediction 
problem, only a few studies investigated the three challenges in MFOP. The authors proposed the multi-
objective radiomics model which considers both sensitivity and specificity as the objective functions 
simultaneously [3], and the predictive results greatly improved compared with single objective based 
radiomics model. Then multi-modality/classifier radiomics model were also investigated, and the case 
studies showed that combining multiple modalities or different classifiers in a reasonable way can 
improve accuracy and reliability of the outcome [6]. However, there has been no a unified model which 
can deal with the three challenges simultaneously in MFOP so far.  
     In this work, a unified framework termed as multifaceted radiomics (M-radiomics) is proposed 
for handling MFOP for the first time. M-radiomics consists of three steps: (1) Multimodal image 
segmentation; (2) Multi-criterion feature extraction and selection; (3) M3 (multi-modality, multi-classifier 
and multi-objective) predictive model construction. Since the tumor locations are same in different 
modalities, it is possible that the tumors are segmented in a collaborative way at first step. In the second 
stage, as the optimal feature subset are not only determined by relevance and redundancy, but also based 
on the predictive performance including sensitivity and specificity, they should be chosen in multi-
criterion way. To overcome the limitation of the conventional single-objective model, M-radiomics 
considers both sensitivity and specificity as objective functions during model training. Instead of 
choosing a preferred classifier or blindly combining features extracted from different modalities, M-
radiomics trains modality-specific classifiers first and then optimally combines the output from the output 
of multiple modality-specific classifiers that is trained according to multiple different criteria such as 
sensitivity and specificity. As such, the three challenges associated with current radiomics are solved 
through multi-modality, multi-classifier and multi-criteria in the proposed M-radiomics.  
            Furthermore, the information extracted from different sources (e.g., modality and classifier) needs 
to be combined to yield a final prediction result in M3 predictive model. Originally designed to combine 
information from different classifiers, the classifier fusion strategy offers an effective solution for both 
multi-modality and multi-classifier models [14-16]. To obtain more reliable predictive results, we propose 
a validating set based reliable fusion (VRF) strategy that not only considers the relative importance 
between different classifiers, but also considers the reliability of the classifier itself. In VRF, reliability of 
the individual classifier output is first determined by considering the output probabilities from the 
validation set. If the output probability of one classifier is similar to most output probabilities in 
validation set, the reliability of this classifier should be high. Both reliability and weight are combined 
with output probabilities of individual classifiers to generate a final output score by an analytical 
evidential reasoning rule [6, 17]. On the other hand, when training the relative weight and the parameters 
in individual classifiers, not only sensitivity and specificity are considered as the objective function, but 
also two new objectives which are similarity based sensitivity and specificity are introduced so as to 
achieve more reliable results. Hence, a new reliable optimization model is proposed. Correspondingly, 
based on our previous work [3], a new recursive two stage hybrid optimization algorithm (RTSH) is 
proposed in this work. In the first stage, iterative multi-objective immune algorithm [3] is performed for 
maximizing sensitivity and specificity, and similarity based multi-objective immune algorithm is 
designed for maximizing similarity based sensitivity and specificity in the second stage. These two stages 
are performed recursively until the algorithm achieves the maximal generation.   
     Two clinically significant problems in head & neck (H&N) cancer are selected to validate the 
performance and reliability of the proposed M-radiomics model. The first problem is predicting distant 
metastasis. Although the locoregional control of H&N cancer after radiotherapy in early stage has been 
improved, the developments of distant metastasis is the leading causes of treatment failure and death [18] 
[19], ranging from 6.1% to 16.3% [20]. For patients at high-risk of distant metastasis after definitive 
treatment, intensification with immediate systemic therapy may reduce the risk of distant relapse and 
improve overall survival. Therefore, accurately predicting of patients with high-risk distant metastasis in 
early stage is central for to improve treatment outcome of H&N cancer patients. Standard of care medical 
images such as 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) and X-ray computed 
tomography (CT) can carry the immense source of potential data for decoding the tumor phenotype [7]. 
When jointly using FDG-PET and CT, it has the unique capability to image metabolically active lesions 
and provide more anatomical details than only PET [21]. The second problem taken up here is to predict 
locoregional recurrence after radiation therapy. Although a great progress has been made in treating H&N 
cancer, a substantial number of patients occur locoregional recurrence within the first three years [22]. 
Early prediction of locoregional recurrence is crucial to improve treatment outcome of these high-risk 
patients by potentially early salvage treatment.  Similar with the first problem, FDG-PET and CT also 
have been considered as a source of prognostic biomarkers for locoregional recurrence prediction. In this 
paper, we exploit the improved and reliable predictive results for the two typical MFOP problems based 
on FDG-PET and CT images through M-radiomics.  
     The reminder of the paper is organized as follows. The problem description for multifactorial outcome 
prediction is described in Section II. Section III describes the proposed M-radiomics model, which 
contains overview, validation set based reliable fusion strategy, reliable optimization model as well as 
recursive two stage hybrid optimization algorithm, training and testing procedures based on M-radiomics. 
Section IV presents the experimental results and analysis for the two prediction problems. The discussion 
is presented in section V and the conclusions are given in section VI. 
II. Problem description 
      Since multifactorial outcome prediction (MFOP) is different from traditional outcome prediction 
problem, its definition is given as follows: 
Definition 1 (Multifactorial outcome prediction (MFOP)): MFOP is defined as predicting outcomes 
through multiple modalities by using different classifiers in multi-criterion way so as to obtain accurate, 
reliable and interpretable results.  
 
(a) 
   
(b) 
Fig. 1: The visualized difference between traditional outcome prediction and multifactorial outcome 
prediction (MFOP). In traditional outcome prediction, there is one modality, one classifier and one 
criterion, while there are multiple modalities, multiple classifiers and multiple criterions in input, model 
construction and output in MFOP. 
    To facilitate understanding, the visualized differences between traditional outcome prediction and 
MFOP are shown in Fig. 1. For a typical traditional prediction problem (Fig. 1 (a)), there is one modality 
as input, one classifier for building the model, and one criterion as output, while MFOP (Fig. 2 (a) ) 
contains multiple modalities as input, multiple classifiers for constructing model, and multiple criterions. 
It can be seen that MFOP is a more generalized framework and the traditional outcome prediction is a 
special case of MFOP. Additionally, the three challenges (multi-modality, multi-classifiers and multi- 
criterion) are distributed in input, model construction and output in MFOP, which covers the most 
important three parts when building the predictive model.  
The aim of MFOP not only obtains more accurate result which is to get the correct output label as 
much as possible, but also gets more reliable result which means maximizing the similarity between 
predicted output probability and true label vector. For example, assume that there are two models (A and 
B) for predicting the outcome and the true label vector is [1, 0]. The predicted output probability for 
model A is [0.9, 0.1], while the output for model B is [0.51, 0.49]. Based on the maximal probability 
output, the predicted label is same for the two models. However, since 0.9 is closer to 1 than 0.51, A is 
more reliable than B. Getting more reliable predictive result is of great importance when making the 
treatment plan. For example, when the output probability of distant failure is more than 0.75, the 
physician may determine adopt additional systemic therapy in lung SBRT. On the other hand, getting an 
interpretable results are also essential. Knowing which features are more important for prediction and 
how they are combined can be very powerful in helping physician understand and trust the whole decision 
procedure, leading to patient survival improvement.   
III. Method 
A. Overview 
      The overall framework of the M-radiomics is shown in Fig. 2, and its definition is as follows: 
Definition 2 (Multifaceted radiomics (M-radiomics)): M-radiomics is defined as extracting a large 
number of quantitative features from multi-modality imaging and analyzing through multiple classifiers 
based on multi-criteria.  
 
Fig. 2: The overall framework of M-radiomics. It consists of multimodal image segmentation, multi-
criterion feature extraction and selection, M3 (multi-modality, multi-classifier and multi-objective) 
predictive model construction.       
     M-radiomics consists of multimodal image segmentation, multi-criterion feature extraction and 
selection, M3 (multi-modality, multi-classifier and multi-objective) predictive model construction. In the 
first step, the regions of interest (e.g. tumor) are segmented in a collaborative way in 𝑀 modalities. Then 
the quantitative features denoted by 𝑓𝑒𝑎𝑖 = {𝑓𝑒𝑎1
𝑖 , 𝑓𝑒𝑎2
𝑖 ,⋯ , 𝑓𝑒𝑎𝑀𝑖
𝑖 }, 𝑖 = 1,⋯ ,𝑀 are extracted from 
segmented region of interest, where Mi represents the feature number for each modality. To achieve the 
accurate, reliable as well as balanced (sensitivity and specificity) performance and select the non-
redundant features for each classifier, the multi-objective based feature selection is necessary. Assume 
that there are 𝑂 objective functions and the goal is to simultaneously maximize all the objective functions: 
𝑓𝑓𝑒𝑎
𝑖 = max𝑓𝑒𝑎𝑖(𝑓1
𝑖 , ⋯ , 𝑓𝑗
𝑖 , ⋯ , 𝑓𝑂
𝑖), 𝑖 = 1,⋯ ,𝑀, 𝑗 = 1,⋯ , 𝑂,   (1) 
The selected features are denoted by 𝑓𝑒𝑎_𝑠𝑖 = {𝑓𝑒𝑎_𝑠1
𝑖 , 𝑓𝑒𝑎_𝑠2
𝑖 , ⋯ , 𝑓𝑒𝑎_𝑠_𝑀𝑖
𝑖 }, 𝑖 = 1,⋯ ,𝑀. In the third 
step, the M3 predictive model will be constructed. Assume that there are 𝑁 classes output and 𝐶 modality-
specific classifiers. When the selected features are fed into the modality-specific classifiers, we can obtain 
the output probability which is denoted by 𝑃𝑐 = {𝑝𝑐
1,⋯ , 𝑝𝑐
𝑛,⋯ , 𝑝𝑐
𝑁}, 𝑐 = 1,⋯ , 𝐶, ∑ 𝑝𝑐
𝑛𝑁
𝑛=1 = 1. Assume 
that the relative weight and model parameters of each modality-specific classifier is denoted by 𝑤𝑐 , 𝑐 =
1,⋯ , 𝐶, 0 ≤ 𝑤𝑐 ≤ 1  and 𝑚𝑝 = {𝑚𝑝1,⋯ ,𝑚𝑝𝑐 , ⋯ ,𝑚𝑝𝐶} , respectively. To obtain more reliable results, 
reliability denote by 𝑟𝑐 , 𝑐 = 1,⋯ , 𝐶, 0 ≤ 𝑟𝑐 ≤ 1 is introduced in validation set based reliable fusion (VRF). 
Hence, the final output probability𝑃𝑓𝑖𝑛 = {𝑝
1,⋯ 𝑝𝑐 , ⋯ , 𝑝𝑐} is inferenced through VRF: 
𝑃𝑓𝑖𝑛 = 𝑉𝑅𝐹(𝑃𝑐 , 𝑤𝑐 , 𝑟𝑐), 𝑐 = 1,⋯ , 𝐶,    (2) 
Furthermore, to obtain more accurate and reliable model, the parameter 𝑚𝑝 and weight 𝑤𝑐 need to be trained. 
The method is same as feature selection process. Assume that there are 𝑃𝑂 objective functions and the goal 
is to maximize the following function: 
𝑓𝑀 = max𝑚𝑝,𝑤𝑐(𝑓1
𝑀, ⋯ 𝑓𝑝𝑜
𝑀 , ⋯ , 𝑓𝑃𝑂
𝑀 ), 𝑐 = 1,⋯ , 𝐶.    (3) 
where 𝑓𝑝𝑜
𝑀 represents the objective function. 
The details of VRF will be described in the following subsection. Additionally, to obtain more reliable 
predictive results, a reliable optimization model as well as a new recursive two stage hybrid optimization 
algorithm (RTSH) is developed in this work, which will be described in the following subsection. On the 
other hand, the whole M-radiomics model is also visible and interpretable. Although several individual 
classifiers (e.g. support vector machine (SVM)) are black-box modelling, they can be interpreted through 
extracting rules [23, 24].    
B. Validation set based reliable fusion strategy 
Reliable fusion is described as fusing the output probability of individual classifiers with both weight 
and reliability, which reliability is the ability to assess a given problem and weight is the relative 
importance to other information sources [6]. In this work, we calculate the reliability and weight based on 
the validation set.  
Assume that there are 𝑁  individual classifiers denoted by 𝐶 = {𝐶1,⋯ , 𝐶𝑁}  with 𝑀  classes, where 
𝑃𝑖 = {𝑝𝑖
1, 𝑝𝑖
2, ⋯ , 𝑝𝑖
𝑀}, 𝑖 = 1,⋯𝑁 is the output probability for a test sample 𝑥. The reliability and weight 
for each individual model are denoted by 𝑟𝑖 and 𝑤𝑖, 𝑖 = 1,⋯ ,𝑁, and the validation set is denoted by 𝑉. 
The final output probability 𝑃𝑓 is obtained through analytic evidential reasoning (AER) rule [6], that is: 
  𝑃𝑓 = 𝐴𝐸𝑅(𝑃𝑖, 𝑤𝑖, 𝑟𝑖), 𝑖 = 1,⋯ ,𝑁,                                             (4) 
The brief description of evidential reasoning and the inference process of AER are shown in Appendix.  
     To achieve this goal, reliability and weight need to be determined. In VRF, reliability is determined by 
the similarity between the output probability of the test sample 𝑥 and output probabilities of K nearest 
neighbors in validation set 𝑉, that is: 
 𝑟𝑖 =
{
 
 
0                                          𝑤ℎ𝑒𝑛 𝑙𝑖 ≠ 𝑙𝑗; 𝑗 = 1,⋯ ,𝐾
1                     𝑤ℎ𝑒𝑛 𝑙𝑖 = 𝑙𝑗 ∧ 𝑝𝑙𝑗 = 1;  𝑗 = 1,⋯ ,𝐾  
0 < 𝑟𝑖 < 1                                 𝑖𝑛 𝑜𝑡ℎ𝑒𝑟 𝑠𝑖𝑡𝑢𝑎𝑡𝑖𝑜𝑛𝑠
 
,                              (5) 
where 𝑙𝑖 is the output labels of test sample 𝑥. 𝑙𝑗 are the output labels of K nearest neighbor samples in 𝑉, 
and 𝑝𝑙𝑗 are the corresponding output probabilities.  
     Since ∑ 𝑝𝑖
𝑚 = 1𝑀𝑚=1 , the output probability for classifier 𝐶𝑖  is the probability density distribution. 
Therefore, calculating the reliability of the classifier 𝐶𝑖 for test sample 𝑥 is transformed into measuring 
the probability distribution similarity. Since dice coefficient is a commonly used probability distribution 
measuring method [25], it is used here. As it is hard to calculate the similarity measure directly, 
dissimilarity measure is calculated at first. Assume that output probability of test sample 𝑥 is denoted by 
𝑝𝑖
𝑚and output probability of one validation sample 𝑣𝑘 , 𝑘 = 1,⋯ ,𝐾 in K nearest neighbors is denoted by 
𝑝𝑖𝑘
𝑚. Based on the dice coefficient, the dissimilarity measure which is denoted by 𝐷𝑖,𝑘(𝑥, 𝑣𝑘) between test 
sample 𝑥 and validation sample 𝑣𝑘 is calculated as: 
𝐷𝑖,𝑘(𝑥, 𝑣𝑘) =
∑ (𝑝𝑖
𝑚−𝑝𝑖𝑘
𝑚)
2
𝑀
𝑚=1
∑ (𝑝𝑖
𝑚)
2𝑀
𝑚=1 +∑ (𝑝𝑖𝑘
𝑚)
2
𝑀
𝑚=1
, 𝑖 = 1,⋯ ,𝑁; 𝑘 = 1,⋯ ,𝐾,                                (6) 
where 𝑖 represents 𝑖𝑡ℎ classifier and 𝑚 represents the 𝑚𝑡ℎ class. 𝑘is the 𝑘𝑡ℎ validation sample in in K 
nearest validation samples. Based on the definition of reliability in equation (5), when 𝑙𝑖 = 𝑙𝑗 ∧ 𝑝𝑙𝑗 =
1;  𝑗 = 1,⋯ ,𝑁, 𝑗 ≠ 𝑖, 𝑟𝑖 = 1. To satisfy this condition, 𝐷𝑖,𝑘(𝑥, 𝑣𝑘)is modified as: 
𝐷𝑖,𝑘(𝑥, 𝑣𝑘) =
∑ (𝑝𝑖
𝑚−𝑝𝑖𝑘
𝑚)
2
𝑀
𝑚=1 ∗∑ (1−𝑝𝑖
𝑙)
2
+∑ (1−𝑝𝑖
𝑙)
2𝑀
𝑚=1
𝑀
𝑚=1
∑ (𝑝𝑖
𝑚)
2𝑀
𝑚=1 +∑ (𝑝𝑖𝑘
𝑚)
2
𝑀
𝑚=1 +∑ (1−𝑝𝑖
𝑙)
2
+𝑀𝑚=1 ∑ (1−𝑝𝑖
𝑙)
2𝑀
𝑚=1
,                                  (7) 
where 𝑝𝑖
𝑙 is the maximal output probability for test sample 𝑥. Then 𝐷𝑖,𝑘(𝑥, 𝑣𝑘)is equally transformed as: 
 𝐷𝑖,𝑘(𝑥, 𝑣𝑘) =
(∑ (𝑝𝑖
𝑚−𝑝𝑖𝑘
𝑚)2𝑀𝑚=1 +1)∗∑ (1−𝑝𝑖
𝑙)2𝑀𝑗=1
∑ (𝑝𝑖
𝑚)
2𝑀
𝑚=1 +∑ (𝑝𝑖𝑘
𝑚)
2
𝑀
𝑚=1 +2∑ (1−𝑝𝑖
𝑙)2𝑀𝑗=1
,                                              (8) 
which deduces the similarity measure between the output probability of test sample 𝑥 and a validation 
sample denoted by: 
𝑆𝑖,𝑘(𝑥, 𝑣𝑘) = 1 −
(∑ (𝑝𝑖
𝑚−𝑝𝑖𝑘
𝑚)2𝑀𝑚=1 +1)∗∑ (1−𝑝𝑖
𝑙)2𝑀𝑗=1
∑ (𝑝𝑖
𝑚)
2𝑀
𝑚=1 +∑ (𝑝𝑖𝑘
𝑚)
2
𝑀
𝑚=1 +2∑ (1−𝑝𝑖
𝑙)2𝑀𝑗=1
,                                           (9) 
where 𝑆𝑖,𝑘(𝑥, 𝑣𝑘) represents the similarity measure. Since there are 𝐾  validation samples, the overall 
similarity denoted by 𝑆𝑖(𝑥) is: 
𝑆𝑖(𝑥) =
1
𝐾
∑ (1 −
(∑ (𝑝𝑖
𝑚−𝑝𝑖𝑘
𝑚)2𝑀𝑚=1 +1)∗∑ (1−𝑝𝑖
𝑙)2𝑀𝑗=1
∑ (𝑝𝑖
𝑚)
2𝑀
𝑚=1 +∑ (𝑝𝑖𝑘
𝑚)
2
𝑀
𝑚=1 +2∑ (1−𝑝𝑖
𝑙)2𝑀𝑗=1
)𝐾𝑘=1 ,                                    (10) 
Assume that 𝑁𝑉 (𝑁𝑉 ≤ 𝐾) is the number of validation samples which the output labels are same as the 
test sample. To make sure the reliability equals 0 when the output labels of all the validation samples are 
different from the output label of test sample, We add 
𝑁𝑉
𝐾
 into 𝑟𝑖(𝑥) , it is: 
𝑟𝑖(𝑥) =
𝑁𝑉
𝐾2
∑ (1 −
(∑ (𝑝𝑖
𝑚−𝑝𝑖𝑘
𝑚)2𝑀𝑚=1 +1)∗∑ (1−𝑝𝑖
𝑙)2𝑀𝑗=1
∑ (𝑝𝑖
𝑚)
2𝑀
𝑚=1 +∑ (𝑝𝑖𝑘
𝑚)
2
𝑀
𝑚=1 +2∑ (1−𝑝𝑖
𝑙)2𝑀𝑗=1
)𝐾𝑘=1 , 𝑖 = 1,⋯ ,𝑁,                    (11) 
Similar to the reliability, the optimal weight 𝑤𝑖 is also determined by measuring the similarity between 
the output probability of test sample and the validation set. Since the only constraint for 𝑤𝑖(𝑥) is 0 ≤
𝑤𝑖 ≤ 1, the dice coefficient can be directly used, that is: 
𝑤𝑖(𝑥) =∑
2∑ 𝑝𝑖
𝑚𝑝𝑖𝑘
𝑚𝑀
𝑚=1
∑ (𝑝𝑖
𝑚)
2
+∑ (𝑝𝑖
𝑚)
2𝑀
𝑚=1
𝑀
𝑚=1
𝐾
𝑘=1 , , 𝑖 = 1,⋯ ,𝑁,                                    (12) 
Same with reliability, when the output labels of all the validation samples are different from the output 
label of test sample, we will let 𝑤𝑖(𝑥) = 0. Therefore, we also add 
𝑁𝑉
𝐾
 into 𝑤𝑖(𝑥), that is: 
𝑤𝑖(𝑥) =  
𝑁𝑉
𝐾
∑
2∑ 𝑝𝑖
𝑚𝑝𝑖𝑘
𝑚𝑀
𝑚=1
∑ (𝑝𝑖
𝑚)
2
+∑ (𝑝𝑖
𝑚)
2𝑀
𝑚=1
𝑀
𝑚=1
𝐾
𝑘=1 , , 𝑖 = 1,⋯ ,𝑁,                                 (13) 
    The final output probability denoted by 𝑝𝑚 for test sample 𝑥 is calculated through AER by fusing the 
output probabilities of all the individual classifiers, that is: 
𝑝𝑚(𝑥) =
𝑘[∏ (
𝑤𝑖𝑝𝑖
𝑚
1+𝑤𝑖−𝑟𝑖
+
1−𝑟𝑖
1+𝑤𝑖−𝑟𝑖
)𝑁𝑖=1 −∏ (
1−𝑟𝑖
1+𝑤𝑖−𝑟𝑖
)𝑁𝑖=1 ]
1−𝑘∏ (
1−𝑟𝑖
1+𝑤𝑖−𝑟𝑖
)𝑁𝑖=1
, 𝑚 = 1,⋯ ,𝑀,                             (14) 
where 𝑘 is: 
𝑘 = [∑ (∏ (
𝑤𝑖𝑝𝑖
𝑚
1+𝑤𝑖−𝑟𝑖
+
1−𝑟𝑖
1+𝑤𝑖−𝑟𝑖
)𝑁𝑖=1 )
𝑀
𝑚=1 − (𝑀 − 1)∏ (
1−𝑟𝑖
1+𝑤𝑖−𝑟𝑖
)𝑁𝑖=1 ]
−1
.                   (15)   
Then the final label 𝐿 for test sample 𝑥 is determined by: 
𝐿(𝑥) = max(𝑝𝑚(𝑥)) ,𝑚 = 1,⋯ ,𝑀.    (16) 
      To show whether Equation (11) meets the definition of reliability, a numerical study is given as 
follows. Assume that there are four individual classifiers for a classification problem with three classes. 
The output probability of classifier 𝐶1 is {0.8, 0.1, 0.1}. Table 1 shows the four group output probabilities 
for other three classifiers, where different groups represent different folders in a four-folder cross 
validation. Without loss of generality, it is assumed that the output probabilities for three models are same 
in all four groups. The reliabilities of 𝐶1  in four groups are 0.7530, 0.8420, 0.9231 and 1.000 from 
Group1 to Group4. In general, the reliability gradually increases from Group1 to Group3 the outputs 
become more similar. On the other hand, although output probability is same in Group3, the reliability is 
still less than 1. Only when all the output probabilities from other classifiers are the same as (1.0, 0.0, 0.0), 
the reliability equals to 1.  
Table 1: Output probabilities for three models in four groups. 
Model Group1 Group2 Group3 Group4 
C2 0.6 0.2 0.2 0.7 0.15 0.15 0.8 0.1 0.1 1.0 0.0 0.0 
C3 0.6 0.2 0.2 0.7 0.15 0.15 0.8 0.1 0.1 1.0 0.0 0.0 
C4 0.6 0.2 0.2 0.7 0.15 0.15 0.8 0.1 0.1 1.0 0.0 0.0 
 
C. Reliable Optimization model 
Since the aim of multifactorial outcome prediction is not only to obtain more accurate results, but also 
get more reliable results, a reliable optimization model for training M-radiomics is desirable. Assume that 
the parameters in M-radiomics is denoted by 𝑀𝑃 = {𝑀𝑃1,𝑀𝑃2,⋯ ,𝑀𝑃𝑃} . To obtain the balanced 
accurate results, both sensitivity and specificity are considered as the objective functions simultaneously. 
Assume that 𝑓𝑠𝑒𝑛 and 𝑓𝑠𝑝𝑒 represent the sensitivity and specificity objective function, respectively. They 
are defined as [3]: 
𝑓𝑠𝑒𝑛 =
𝑇𝑃
𝑇𝑃+𝐹𝑁 
,   𝑓𝑠𝑝𝑒 =
𝑇𝑁
𝑇𝑁+𝐹𝑃 
,                                                       (17) 
where 𝑇𝑃 is the number of true positives, 𝑇𝑁 is the number of true negatives, 𝐹𝑃 is the number of false 
positives, and 𝐹𝑁 is the number of false negatives. The aim is to maximize the two objective functions 
simultaneously, that is: 
𝑓𝑎𝑐𝑐 = max𝑀𝑃(𝑓𝑠𝑒𝑛, 𝑓𝑠𝑝𝑒),     (18) 
where 𝑓𝑎𝑐𝑐 represents the accuracy based objective function.  
     On the other hand, reliability based objective function denoted by 𝑓𝑟𝑒𝑙 is also needed. Inspired by the 
sensitivity and specificity, we define the similarity based sensitivity and specificity, which are denoted by 
𝑓𝑠𝑖𝑚_𝑠𝑒𝑛, 𝑓𝑠𝑖𝑚_𝑠𝑝𝑒, respectively. Assume that 𝑃𝑡𝑝 = {𝑝𝑡𝑝
1 , 𝑝𝑡𝑝
2 ,⋯ , 𝑝𝑡𝑝
𝑇𝑃} represents the probability output of 
true positives and the corresponding labelled vector is 𝑇𝑡𝑝 = {𝑝𝑡𝑝
1 , 𝑝𝑡𝑝
2 ,⋯ , 𝑝𝑡𝑝
𝑇𝑃} . Based on the dice 
coefficient, the similarity measure of true positives 𝑇𝑃𝑠𝑖𝑚 is: 
𝑇𝑃𝑠𝑖𝑚 = ∑ 𝑠𝑖𝑚(𝑝𝑡𝑝
𝑘 , 𝑇𝑡𝑝
𝑘 )𝑇𝑃𝑘=1 = ∑
2∑ 𝑝𝑡𝑝,𝑗
𝑘 𝑇𝑡𝑝,𝑗
𝑘𝑁
𝑗=1
∑ (𝑝𝑡𝑝,𝑗
𝑘 )
2
+∑ (𝑇𝑡𝑝,𝑗
𝑘 )
2
𝑁
𝑗=1
𝑁
𝑗=1
𝑇𝑃
𝑘=1 ,                              (19) 
Similarly, we can get the similarity measure of true negatives, false positives and false negatives, which 
are denoted by 𝑇𝑁𝑠𝑖𝑚, 𝐹𝑃𝑠𝑖𝑚 and 𝐹𝑁𝑠𝑖𝑚, respectively. Similar with the sensitivity and specificity, we can 
also obtain 𝑓𝑠𝑖𝑚_𝑠𝑒𝑛, 𝑓𝑠𝑖𝑚_𝑠𝑝𝑒, they are: 
𝑓𝑠𝑖𝑚_𝑠𝑒𝑛 =
𝑇𝑃𝑠𝑖𝑚
𝑇𝑃𝑠𝑖𝑚+𝐹𝑁𝑠𝑖𝑚 
,   𝑓𝑠𝑖𝑚_𝑠𝑝𝑒 =
𝑇𝑁𝑠𝑖𝑚
𝑇𝑁𝑠𝑖𝑚+𝐹𝑃𝑠𝑖𝑚 
,                                       (20) 
These two type objective functions constitute the reliability based objective function 𝑓𝑟𝑒𝑙, that is: 
𝑓𝑟𝑒𝑙 = max𝑀𝑃 (𝑓𝑠𝑖𝑚𝑠𝑒𝑛 , 𝑓𝑠𝑖𝑚𝑠𝑝𝑒) .    (21) 
      Since 𝑓𝑎𝑐𝑐  describes the label output and 𝑓𝑟𝑒𝑙  shows the probability output, they are correlated. 
However, when performing multi-objective optimization, the objective functions have be conflict among 
each other. Therefore, instead of optimizing the two type objective functions, we train them alternatively 
and a new recursive two stage hybrid optimization algorithm (RTSH) is proposed. RTSH consists of two 
stages, which the first stage is to train the accuracy based objective function and the second stage is to 
maximize the reliability based objective function. For the first stage, our previous proposed iterative 
multi-objective immune algorithm (IMIA) [3] is adopted. To improve the reliability in the second stage, 
we design a similarity-based multi-objective optimization algorithm (SMO) [26]. These two stages are 
performed recursively until the algorithm achieves the maximal generation.  
D. Recursive two stage hybrid optimization algorithm 
     Before describing the proposed RTCH, IMIA is briefly described as follows. 
     Step 1 – Initialization: Model parameters are optimized directly as the value is continuous. We use 
Gmax to denote the maximum number of generations and 𝐷(𝑗) = {𝑑1,⋯ , 𝑑𝑃} denote the population, with 
P as the number of individuals in one population.  
     Step 2 – Clonal operation: Proportional cloning will be used in this study[27]. To diversify the 
population, an individual with a larger crowding-distance is reproduced more times, and the clonal time 
qi  for each individual is calculated as:𝑞𝑖 = ⌈𝑛𝑐 ×
𝛿(𝑑𝑖,𝐷)
∑ 𝛿(𝑑𝑗,𝐷)
|𝐴|
𝑗=1
⌉, where 𝑛𝑐  is the expectant value of the 
clonal population and ⌈ ⌉ is the ceiling operator. 𝛿(𝑑𝑖 , 𝐷) represents the crowding distance.  
     Step 3 – Mutation operation: The mutation operation will be performed on the cloned population 𝐶(𝑗). 
For each locus in the individual, a random mutation probability (𝑀𝑃𝑖) will be generated. If 𝑀𝑃𝑖   is larger 
than a general mutation probability (𝐺𝑀𝑃𝑖), the mutation will occur. The mutated population is denoted 
by 𝑀(𝑗). 𝐷(𝑗) and 𝑀(𝑗) are combined to form a new population 𝐹(𝑗).  
    Step 4 – Deleting operation: If there are duplicated solutions in the new population 𝐹(𝑗), we will only 
keep the unique one and delete other duplicated solutions. If the size of F(j) is less than P, step 2 should 
be used to generate more mutated individuals; otherwise, step 5 should be used. In contrast to other 
immune-inspired algorithms, this deleting operation is a new operator of the proposed IMIA. When the 
same solutions are generated in the Pareto-optimal set, the diversity of the individuals in a population will 
be reduced. We will perform the deleting operation to ensure that all the solutions in the Pareto-optimal 
set are different after executing the clonal and mutation operations.  
    Step 5 – Updating population: The selected features and model parameters for each individual are taken 
as the input for model. Then, 𝑓𝑠𝑒𝑛 and 𝑓𝑠𝑝𝑒 are calculated through a cross-validation. The individual in all 
feasible solutions is sorted in the descending order using a fast non-dominated sorting approach[28] 
according to the AUC of each solution. We will obtain the Pareto-optimal set according to AUC because 
it is one of the most important criteria for the performance evaluation of a predictive model. 
A Pareto-optimal solution set is generated after finish training. SMO is similar with IMIA in most 
steps except from step 2 and step 5. In step 2, a new similarity-based proportional cloning operation was 
proposed, where the solution with higher similarity was reproduced multiple times. Specifically, the 
clonal time CLTi for each solution is calculated as: 
𝐶𝐿𝑇𝑖 = ⌈𝑛𝑐 ×
𝑠𝑖𝑚(𝑑𝑖)
∑ 𝑠𝑖𝑚(𝑑𝑖)
𝐻
𝑖=1
⌉,                             (22) 
where 𝑛𝑐 is the expected value of the clonal solution set and ⌈ ⌉ is the ceiling operator. The similarity 
measure for solution 𝑑𝑖 denoted by 𝑠𝑖𝑚(𝑑𝑖) is calculated as: 
𝑠𝑖𝑚(𝑑𝑖) = ∑
2∑ 𝑃𝑗
𝑘𝑇𝑗
𝑘𝑁
𝑗=1
∑ (𝑃𝑗
𝑘)
2
+∑ (𝑇𝑗
𝑘)
2
𝑁
𝑗=1
𝑁
𝑗=1
𝐾
𝑘=1 ,                       (23) 
where 𝐾 is the number of training samples and 𝑇𝑗
𝑘 is the label vector. In step 5, the solution in is sorted in 
the descending order using the fast non-dominated sorting approach according to reliability based 
objective function of each solution. The procedures of RTCH is shown in table 2, where 𝑅 is the maximal 
generation. After generating the Pareto-optimal solution set, the optimal solution is selected based on the 
area under the curve (AUC) and accuracy. 
Table 2: Procedures of RTCH. 
Input: Initial population, set 𝑟 = 0, 𝑗 = 0. 
while 𝑟 < 𝑅 
     Stage 1: while 𝑗 < 𝐺, perform IMIA: 
                        Step 1: Proportional clonal operation.  
                        Step 2: Static mutation operation. 
                        Step 3: Deleting operation. 
                            Step 4: AUC based fast nondominated sorting approach 
for updating solution set. 
                    End while 
          Stage 2: while 𝑗 < 𝐺, perform SMO: 
                             Step 1: similarity-based proportional cloning operation. 
                             Step 2: Static mutation operation. 
                             Step 3: Deleting operation. 
                             Step 4: Similarity based fast nondominated sorting 
approach for updating solution set. 
                         End while 
End while 
Output: Pareto-optimal solution set. 
D. Training and testing procedures 
     In this subsection, the training and testing procedures of M-radiomics for handling two MFOP 
problems in H&N cancer is described. Since the tumor is segmented manually, the training part mainly 
consists of feature extraction, feature selection and predictive model construction. Totally 257 features 
including intensity, texture and geometry features are extracted for FDG-PET and CT images, 
respectively. When applying RTSH for multi-criterion selecting features, the binary initialization is 
adopted, which “1” represents the selected feature and “0” represents the unselected feature. During the 
M3 model construction, six different individual classifiers are used, including support vector machine, 
logistic regression (LR), discriminant analysis (DA), decision tree (DT), K-nearest-neighbor (KNN), and 
naive Bayesian (NB). Hence, there are 12 modality-specific individual classifiers.  
    The testing part also divides into three stages. For a test sample, first, the features for each modality-
specific classifier are selected at first stage. In the second stage, each modality-specific classifier outputs a 
probability. At final stage, the final probability is obtained by combining all the output probabilities as 
well as reliability and weight using the VRF. Then, and the label with maximal output probability is 
determined as the final label output.  
IV. Experiments 
A. Dataset description 
   For distant metastasis prediction in H&N cancer, FDG-PET and radiotherapy planning CT from 188 
patients are used. All patients had pre-treatment FDG-PET/CT scans between April 2006 and November 
2017. The follow up time ranges from 6 months to 112 months and the median follow up time is about 43 
months. Sixteen percent (16%) of these patients had distant metastasis. All the image features are 
extracted from 3D tumor provided by TCIA. For predicting locoregional recurrence, FDG-PET and CT 
from 100 patients with definitive radiation therapy were retrospectively used. Among these patient data, 
40 patients experienced locoregional recurrence. 
B. Setup 
     When building the M-radiomics model for two clinical problems, four group experiments were 
designed in this study so that the effectiveness of M-radiomics as well as new RCF and RTSH can be 
comprehensively validated. They are: (1) multi-modality evaluation; (2). Multi-classifier evaluation; (3) 
validating RTSH; (4) new RCF (RCF-II) validation. All the experiments performed two-fold cross-
validation. Sensitivity (SEN), specificity (SPE), area under the curve (AUC) and accuracy (ACC) were 
used to evaluate the performance. Additionally, the reliability is evaluated through the similarity based 
sensitivity and specificity.  
     In addition to two single modality (PET, CT) in the first experiment, the method which directly 
combined three modality features (named as DCM) was also compared with M-radiomics. To reduce the 
effect of other factors, only support vector machine (SVM) is used for modelling. Three modalities are 
used in our proposed way in the following three experiments. In the second experiment, six individual 
classifiers, including SVM, logistic regression (LR), discriminant analysis (DA), decision tree (DT), K-
nearest-neighbor (KNN), and naive Bayesian (NB) were used for comparison. IMIA was used for 
optimizing in the above two experiments. In the third experiment, the single objective (SO) based 
optimization method [4] and IMIA were performed for comparison. The recursive time is set as 5 and the 
generation time in each recursion is set as 20 in RTSH. The population number as well as maximal 
generation was set as 100 in IMIA and SO, while the clonal factor was set as 200 and the mutation rate 
was set as 0.9 in IMIA. The previous RCF (RCF-I), evidential reasoning fusion (ERF) and weighted 
fusion (WF) were compared with RCF-II and RTSH is applied in the final experiment.   
C. Results and analysis for study 1 
    The evaluation results on four modalities are shown in table 3. MR performs best in ACC and SEN, 
while DCM and Clinic obtains best ACC and SPE, respectively. It shows the combined models 
outperform single modality based models. MR also outperforms DCM in three criterions and only AUC is 
slightly lower, which means that the proposed combined method is more reasonable. Table 4 presents the 
results of six individual classifiers and combined model, among which MR performs best. This is because 
different classifiers improve the diversity of output, which makes the combined model be more robust. 
Three optimization algorithms are compared in the third experiment as shown in table 5 while the results 
of different fusion strategies shown in table 6. It shows that RTSF can obtain the best performance except 
from AUC as AUC is considered as the objective function in SO. RCF-II outperforms other three fusion 
strategies in all four criterions because of the advantages of new reliability calculation method and the 
way of optimizing relative weight.      
Table 3. Evaluation results on five modalities. 
Modality AUC ACC SEN SPE 
Clinic 0.6804 0.7294 0.5333 0.7785 
PET 0.6363 0.7243 0.5000 0.7658 
CT 0.7094 0.6649 0.6333 0.6709 
DCM 0.7181 0.6702 0.6333 0.6772 
MR 0.7175 0.7347 0.6667 0.7595 
Table 4. Evaluation results on six classifiers and combined results. 
Classifier AUC ACC SEN SPE 
DA 0.7264 0.6542 0.6333 0.6519 
DT 0.6592 0.7181 0.5333 0.7532 
KNN 0.7158 0.7287 0.6000 0.7341 
LR 0.7124 0.6915 0.6667 0.6962 
NB 0.6224 0.5957 0.6667 0.5886 
SVM 0.7175 0.7347 0.6667 0.7395 
M-radiomics 0.7340 0.7387  0.6667 0.7455  
 
  
  AUC ACC SEN SPE 
SO 0.7595 0.7074 0.6333 0.7215 
IMIA 0.7340 0.7387 0.6667 0.7455 
RTSF 0.7500 0.7478 0.6667 0.7595 
  AUC ACC SEN SPE 
WF 0.7325 0.7074 0.6667 0.7125 
DSF 0.7068 0.6649 0.6667 0.6646 
RCF-I 0.7331 0.7340 0.6667 0.7435 
RCF-II 0.7500 0.7478 0.6667 0.7595 
Table 6. Evaluation results on four fusion strategies. Table 5. Evaluation results on three 
optimization algorithms. 
  
D. Results and analysis for study 2 
AUC, accuracy (ACC) sensitivity (SEN) and specificity (SPE) were taken as the evaluation criteria. 
Three modalities including PET, CT and PET & CT were used and two-folder cross-validation was 
performed. Table 7 shows the predictive results of three modalities, and table 8 shows the results of six 
individual classifier based radiomics and M-radiomics with PET&CT as input. Other than SEN, PET&CT 
modelling with M-radiomics obtains best performance in another three criteria.  
 
Table 7: Predictive performance for three modalities. 
Modality AUC ACC SEN SPE 
PET 0.7473 0.7300 0.6500 0.7833 
CT 0.7633 0.7500 0.6500 0.8167 
PET&CT 0.7848 0.7800 0.6500 0.8667 
Table 8: Predictive results for six individual classifiers and M-radiomics.  
classifier AUC ACC SEN SPE 
SVM 0.7308 0.7200 0.6500 0.7667 
LR 0.7292 0.6700 0.6250 0.7000 
DA 0.7129 0.7000 0.6000 0.7667 
DT 0.7571 0.7300 0.6500 0.7833 
KNN 0.7413 0.7100 0.5500 0.8167 
NB 0.7173 0.7300 0.6000 0.8167 
M-radiomics 0.7848 0.7800 0.6500 0.8667 
 
VI. Conclusions 
In this work, a new problem termed as multifactorial outcome prediction (MFOP) was proposed. Three 
mainly challenges including multi-modality, multi-classifier and multi-criterion are integrated into a 
unified framework. The aim of MFOP is to obtain more accurate, more reliable and interpretable 
predictive results.  
To handle the new MFOP, a new multifaceted radiomics (M-radiomics) model was proposed. M-
radiomics consists of three parts, they are multimodal image segmentation, multi-criterion feature 
extraction and selection, M3 (multi-modality, multi-classifier and multi-objective) predictive model 
construction. The above three challenges are handled very well through M-radiomics.  
 We also developed a validation set based reliable fusion strategy (VRF) and a reliable optimization 
model in M-radiomics so as to improve the reliability of predictive results. In VRF, reliability as well as 
weight is introduced, and they were calculated based on the similarity measure between the output 
probability of test sample and validation sample set. In reliable optimization model, similarity based 
sensitivity and specificity were introduced to maximize the reliability, and a new recursive two stage 
hybrid optimization algorithm (RTSH) was proposed. This two stage optimization algorithm can ensure 
that M-radiomics can obtain accurate and reliable predictive results.  
Two clinical problems including distant metastasis and locoregional recurrence prediction in H&N 
cancer were modelled through M-radiomics. The experimental results demonstrated that M-radiomics 
model outperformed current typical radiomics models. Compared with other fusion strategies and 
optimization algorithms, the proposed VRF and RTSH can obtain more reliable predictive results.   
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Appendix  
A. Brief description of evidential reasoning rule 
Assume that 𝛩 = {ℎ1, ℎ2, ⋯ , ℎ𝐻}  is a set of mutually exclusive and collectively exhaustive 
hypotheses, where 𝛩 is referred to as a frame of discernment. The power set of 𝛩 consists of all its 
subsets, denoted by 𝑃(𝛩) or 2𝛩, as follows: 
𝑃(𝛩) = 2𝛩 = {∅, {ℎ1},⋯ , {ℎ𝐻}, {ℎ1, ℎ2},⋯ , {ℎ1, ℎ𝑀},⋯ , {ℎ1, ℎ𝐻−1}, 𝛩},               (A.1) 
where {ℎ1, ℎ2},⋯ , {ℎ1, ℎ𝑀},⋯ , {ℎ1, ℎ𝐻−1} are the local ignorance. In the ER rule, a piece of evidence 𝑒𝑖 
is represented as a random set and profiled by a belief distribution (BD), as: 
𝑒𝑖 = {(𝜃, 𝑝𝜃,𝑖), ∀𝜃 ⊆ 𝛩,∑ 𝑝𝜃,𝑖 = 1𝜃⊆𝛩 },                                        (A.2) 
where (𝜃, 𝑝𝜃,𝑖) is an element of evidence 𝑒𝑖, indicating that the evidence points to proposition 𝜃, which 
can be any subset of 𝛩 or any element of 𝑃(𝛩) except from the empty set, to the degree of 𝑝𝜃,𝑖 referred to 
as probability or degree of belief, in general. (𝜃, 𝑝𝜃,𝑖) is referred to as a focal element of 𝑒𝑖 if 𝑝𝜃,𝑖 > 0. 
The reasoning process in the ER rule is performed by defining a weighted belief distribution with 
reliability (WBDR) [29]: 
 𝑚𝑖 = {(𝜃, ?̃?𝜃,𝑖), ∀𝜃 ⊆ Θ; (𝑃(Θ), ?̃?𝑃(𝛩),𝑖},                                          (A.3) 
where ?̃?𝜃,𝑖 measures the degree of support for 𝜃 from 𝑒𝑖 with both weight and reliability being taken into 
account, defined as follows: 
?̃?𝜃,𝑖 = {
0,         𝜃 = ∅
𝑐𝑟𝑤,𝑖𝑚𝜃,𝑖,     𝜃 ⊆ 𝛩, 𝜃 ≠ ∅ 
𝑐𝑟𝑤,𝑖(1 − 𝑟𝑖),     𝜃 = 𝑃(𝛩)
  𝑜𝑟 ?̃?𝜃,𝑖 = {
0,         𝜃 = ∅
?̃?𝑖𝑝𝜃,𝑖,     𝜃 ⊆ 𝛩, 𝜃 ≠ ∅ 
1 − ?̃?𝑖,     𝜃 = 𝑃(𝛩)
.                   (A.4)                                        
𝑚𝜃,𝑖 = 𝑤𝑖𝑝𝜃,𝑖 𝑎𝑛𝑑 𝑐𝑟𝑤,𝑖 = 1/(1 + 𝑤𝑖 − 𝑟𝑖)  is a normalization factor, which satisfies ∑ ?̃?𝜃,𝑖 +𝜃⊆𝛩
?̃?𝑃(𝜃),𝑖 = 1. ?̃?𝑖 = 𝑐𝑟𝑤,𝑖𝑤𝑖 , is acting as a new weight. Then the ER rule combines multiple pieces of 
evidence recursively. If two pieces of evidence 𝑒1  and 𝑒2  are independent, 𝑒1  and 𝑒2  jointly support 
proposition 𝜃 denoted by 𝑝𝜃,𝑒(2), which is generated as follows: 
𝑝𝜃,𝑒(2) = {
0                 𝜃 = ∅
?̂?𝜃,𝑒(2)
∑ ?̂?𝐷,𝑒(2)𝐷⊆Θ
     𝜃 ⊆ 𝛩, 𝜃 ≠ ∅,                                                 (A.5) 
?̂?𝜃,𝑒(2) = [(1 − 𝑟2)𝑚𝜃,1 + (1 − 𝑟1)𝑚𝜃,2] + ∑ 𝑚𝐵,1𝑚𝐶,2𝐵∩𝐶=𝜃              ∀𝜃 ⊆ 𝛩,             (A.6) 
When there are 𝐿 pieces of independent evidence, the jointly support proposition 𝜃 denoted by ?̂?𝜃,𝑒(𝐿) 
can be generated by the following two equations: 
?̂?𝜃,𝑒(𝐿) = [(1 − 𝑟𝑖)𝑚𝜃,𝑒(𝑖−1) +𝑚𝑃(𝛩),𝑒(𝑖−1)𝑚𝜃,𝑖] + ∑ 𝑚𝐵,𝑒(𝑖−1)𝑚𝐶,𝑖𝐵∩𝐶=𝜃 , ∀𝜃 ⊆ 𝛩,      (A.7) 
?̂?𝑃(𝛩),𝑒(𝐿) = (1 − 𝑟𝑖)𝑚𝑃(𝛩),𝑒(𝑖−1),                                             (A.8) 
After obtaining the normalization, the combined BD 𝑝𝜃 can be calculated by the following equation: 
𝑝𝜃 =
?̂?𝜃,𝑒(𝐿)
1−?̂?𝑃(𝛩),𝑒(𝐿)
, ∀𝜃 ⊆ 𝛩.                                                        (A.9)  
B. Inference of analytic evidential reasoning rule 
As there’s no local ignorance in outcome prediction, they are pruned in ER rule. Under no local 
ignorance, the BD for each evidence 𝑒𝑖 is reduced to the following format: 
𝑒𝑖 = {(𝜃ℎ, 𝑝ℎ,𝑖), ℎ = 1,⋯ ,𝐻; ∑ 𝑝ℎ,𝑖
𝑀
𝜃ℎ=1
= 1}, 𝑖 = 1,⋯ ,𝑁                    (B.1)       
And WBDR is reduced to: 
 𝑚𝑖 = {(𝜃ℎ, ?̃?𝑖𝑝ℎ,𝑖), ℎ = 1,⋯ ,𝐻; (𝑃𝑖(𝛩), (1 − ?̃?𝑖)}, 𝑖 = 1,⋯ ,𝑁                  (B.2) 
where 𝜃ℎ is the class and 𝑝ℎ,𝑖 is the corresponding output score of individual classifier 𝑖. ?̃?𝑖 is the new 
weight. 
Since normalization in the evidence combination can be applied at the end of the process without 
changing the combination result, we do not consider normalization when combining all the evidence but 
apply it in the end. Assume that ?̂?𝜃ℎ,𝑙 , ℎ = 1,⋯ ,𝐻  and ?̂?𝑃(Θ),𝑙  denote the WBDR generated by 
combining the first 𝑙 evidence. We first consider a condition of 𝑙 = 2: the combination of two evidences 
(output scores from two classifiers) without normalization. The combined WBDR generated by 
aggregating the two evidences by orthogonal sum operation are given as follows.  
?̂?𝜃ℎ,2 = 𝑚𝜃ℎ,1𝑚𝑃(𝛩),2 +𝑚𝜃ℎ,2𝑚𝑃(𝛩),1 +𝑚𝜃ℎ,1𝑚𝜃ℎ,2                                                                       (B.3) 
            = 𝑚𝜃ℎ,1(𝑚𝜃ℎ,2 +𝑚𝑃(𝛩),2) +𝑚𝜃ℎ,2𝑚𝑃(𝛩),1 
            = 𝑚𝜃ℎ,1(𝑚𝜃ℎ,2 +𝑚𝑃(𝛩),2) +𝑚𝑃(𝛩),1(𝑚𝜃ℎ,2 +𝑚𝑃(𝛩),2) − 𝑚𝑃(𝛩),1𝑚𝑃(𝛩),2 
            = (𝑚𝜃ℎ,1 +𝑚𝑃(𝛩),1)(𝑚𝜃ℎ,2 +𝑚𝑃(𝛩),2) − 𝑚𝑃(𝛩),1𝑚𝑃(𝛩),2 
          =∏(𝑚𝜃ℎ,𝑖 +𝑚𝑃(Θ),𝑖)
2
𝑖=1
−∏𝑚𝑃(𝛩),𝑖
2
𝑖=1
, 
And 
?̂?𝑃(Θ),2 = ∏ 𝑚𝑃(𝛩),𝑖
2
𝑖=1 ,                                                   (B.4) 
Assume that the following equations are true for the (l-1) evidences. Let 𝑙1 = 𝑙 − 1 and: 
?̂?𝜃ℎ,𝑙1 = ∏ (𝑚𝜃ℎ,𝑖 +𝑚𝑃(Θ),𝑖)
𝑙−1
𝑖=1 −∏ 𝑚𝑃(𝛩),𝑖
𝑙−1
𝑖=1 ,                                 (B.5) 
?̂?𝑃(Θ),𝑙1 = ∏ 𝑚𝑃(𝛩),𝑖
𝑙−1
𝑖=1 ,                                                  (B.6) 
The above combined probability masses are further aggregated with the lth evidence. The combined 
probability masses are given as: 
?̂?𝜃,𝑙 = ?̂?𝜃ℎ,𝑙1𝑚𝜃ℎ,𝑙 + ?̂?𝜃ℎ,𝑙1𝑚𝑃(Θ),𝑙 +𝑚𝜃ℎ,𝑙?̂?𝑃(Θ),𝑙1                                                                      (B.7) 
         = ?̂?𝜃ℎ,𝑙1(𝑚𝜃ℎ,𝑙 +𝑚𝑃(Θ),𝑙) + 𝑚𝜃ℎ,𝑙?̂?𝑃(Θ),𝑙1 
        = ?̂?𝜃ℎ,𝑙1(𝑚𝜃ℎ,𝑙 +𝑚𝑃(Θ),𝑙) + ?̂?𝑃(Θ),𝑙1(𝑚𝜃ℎ,𝑙 +𝑚𝑃(Θ),𝑙) − ?̂?𝑃(Θ),𝑙1𝑚𝑃(Θ),𝑙 
        = (?̂?𝜃ℎ,𝑙1 + ?̂?𝑃(Θ),𝑙1)(𝑚𝜃ℎ,𝑙 +𝑚𝑃(Θ),𝑙) − ?̂?𝑃(Θ),𝑙1𝑚𝑃(Θ),𝑙 
        
       = (𝑚𝜃ℎ,𝑙 +𝑚𝑃(Θ),𝑙)((∏ (𝑚𝜃ℎ,𝑖 +𝑚𝑃(Θ),𝑖)
𝑙−1
𝑖=1 −∏ 𝑚𝑃(𝛩),𝑖
𝑙−1
𝑖=1 ) + ∏ 𝑚𝑃(𝛩),𝑖
𝑙−1
𝑖=1 ) −
               𝑚𝑃(Θ),𝑙∏ 𝑚𝑃(𝛩),𝑖
𝑙−1
𝑖=1  
        = ∏ (𝑚𝜃ℎ,𝑖 +𝑚𝑃(Θ),𝑖)
𝑙
𝑖=1 −∏ 𝑚𝑃(𝛩),𝑖,
𝑙
𝑖=1  
And 
?̂?𝑃(Θ),𝑙 = 𝑚𝑃(Θ),𝑙?̂?𝑃(Θ),𝑙1 = 𝑚𝑃(Θ),𝑙∏ 𝑚𝑃(𝛩),𝑖
𝑙−1
𝑖=1 = ∏ 𝑚𝑃(𝛩),𝑖,
𝑙
𝑖=1                     (B.8) 
Then we normalize the combined WBDR results. Assume that 𝑘 is the normalization factor, therefore  
𝑘(∑ ?̂?𝜃ℎ,𝑙
𝐻
ℎ=1 + ?̂?𝑃(Θ),𝑙) = 1,                                                     (B.9) 
That is: 
𝑘(∑ (∏ (𝑚𝜃ℎ,𝑖 +𝑚𝑃(Θ),𝑖)
𝑙
𝑖=1 −∏ 𝑚𝑃(Θ),𝑖
𝑙
𝑖=1 )
𝐻
ℎ=1 +∏ 𝑚𝑃(Θ),𝑖
𝑙
𝑖=1 ) = 1,             (B.10) 
𝑘(∑ (∏ (𝑚𝜃ℎ,𝑖 +𝑚𝑃(Θ),𝑖)
𝑙
𝑖=1 )
𝐻
ℎ=1 ) − 𝑘(𝐻 − 1)∏ 𝑚𝑃(Θ),𝑖
𝑙
𝑖=1 = 1,                   (B.11) 
So 
𝑘 = (∑ (∏ (𝑚𝜃ℎ,𝑖 +𝑚𝑃(Θ),𝑖)
𝑙
𝑖=1 )
𝐻
ℎ=1 − (𝐻 − 1)∏ 𝑚𝑃(Θ),𝑖
𝑙
𝑖=1 )
−1
,                    (B.12) 
Therefore,  
𝑚𝜃,𝑙 = 𝑘?̂?𝜃,𝑙 , 𝑚𝑃(Θ),𝑙 = 𝑘?̂?𝑃(Θ),𝑙 ,                                       (B.13) 
where 𝑚𝜃,𝑙  and 𝑚𝑃(Θ),𝑙  are the combined WBDR after normalization. So the BD 𝑝𝑚after combining l 
evidence is: 
𝑝ℎ =
𝑚𝜃,𝑙
1−𝑚𝑃(𝛩),𝑙
=
𝑘?̂?𝜃,𝑙
1−𝑘?̂?𝑃(Θ),𝑙
=
𝑘(∏ (𝑚𝜃,𝑖+𝑚𝑃(Θ),𝑖)
𝑙
𝑖=1 −∏ 𝑚𝑃(𝜃),𝑖
𝑙
𝑖=1 )
1−𝑘∏ 𝑚𝑃(𝜃),𝑖
𝑙
𝑖=1
, ℎ = 1,⋯ ,𝐻,             (B.14) 
Based on Eq. (A.4) and 𝑙 = 𝑁, the final BD is: 
𝑝ℎ =
𝑘[∏ (
𝑤𝑖𝑝ℎ,𝑖
1+𝑤𝑖−𝑟𝑖
+
1−𝑟𝑖
1+𝑤𝑖−𝑟𝑖
)𝑁𝑖=1 −∏ (
1−𝑟𝑖
1+𝑤𝑖−𝑟𝑖
)𝑁𝑖=1 ]
1−𝑘∏ (
1−𝑟𝑖
1+𝑤𝑖−𝑟𝑖
)𝑁𝑖=1
, ℎ = 1,⋯ ,𝐻,                             (B.15) 
and 𝑘 is:  
𝑘 = [∑ (∏ (
𝑤𝑖𝑝ℎ,𝑖
1+𝑤𝑖−𝑟𝑖
+
1−𝑟𝑖
1+𝑤𝑖−𝑟𝑖
)𝑁𝑖=1 )
𝐻
ℎ=1 − (𝐻 − 1)∏ (
1−𝑟𝑖
1+𝑤𝑖−𝑟𝑖
)𝑁𝑖=1 ]
−1
.                  (B.16) 
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